(Q39606100)

13 September 2017

1 reference

title

Role of arachidonic acid metabolites in cardiac ischemia and reperfusion injury (English)

1 reference

13 September 2017

1 reference

Fiedler VB

1

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

13 September 2017

1 reference

13 September 2017

volume

8

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

158-168

1 reference

Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Leukocytes and ischemia-induced myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Reperfusion injury: laboratory artifact or clinical dilemma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Toxic properties of arachidonic acid on normal, ischemic and reperfused hearts. Indirect evidence for free radical involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Calcium antagonists and the ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Stimulated synthesis of prostaglandin E2 or leukotrien C4 from myocardial cells is not a cause but a result of their injury under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Prostaglandins and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

A role for PAF-acether (platelet-activating factor) in platelet-dependent vascular diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Role of oxygen radicals in cardiac injury due to reoxygenation*

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

The release of a leukotriene D4-like substance following myocardial infarction in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Leukotrienes and the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Effect of PGE1, PGE2 and PGI2 on ventricular arrhythmias during myocardial infarction in conscious dogs: relation to infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Prostacyclin in experimental myocardial ischemia: effects on hemodynamics, regional myocardial blood flow, infarct size and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Myocardial prostaglandin E release by nitroglycerin and modification by indomethacin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Molsidomine: alternative approaches to treat myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Enhancement of canine coronary collateral flow by nafazatrom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Aspirin inhibits the early myocardial release of thromboxane B2 and ventricular ectopic activity following acute coronary artery occlusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Effect of indomethacin on collateral blood flow and infarct size in the conscious dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Prostaglandins and the control of blood flow in the canine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Coronary Vasoconstrictor Effect of Indomethacin in Patients with Coronary-Artery Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Influence of sulfinpyrazone and naproxen on infarct size in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Ibuprofen inhibits granulocyte responses to inflammatory mediators. A proposed mechanism for reduction of experimental myocardial infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1875-9114.1988.TB04070.X

10.1002/J.1875-9114.1988.TB04070.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference